172 related articles for article (PubMed ID: 36343537)
1. LC and LC-MS/MS studies for identification and characterization of degradation products of d-tubocurarine chloride.
Grover P; Maheshwari S; Nagarajan K; Mehta L; Kumar S; Rastogi C
J Pharm Biomed Anal; 2023 Jan; 223():115119. PubMed ID: 36343537
[TBL] [Abstract][Full Text] [Related]
2. LC and LC-MS/MS studies for identification and characterization of new degradation products of ibrutinib and elucidation of their degradation pathway.
Mehta L; Naved T; Grover P; Bhardwaj M; Mukherjee D
J Pharm Biomed Anal; 2021 Feb; 194():113768. PubMed ID: 33279300
[TBL] [Abstract][Full Text] [Related]
3. Liquid chromatography/electrospray ionization tandem mass spectrometry study of repaglinide and its forced degradation products.
Purna Chander C; Raju B; Ramesh M; Shankar G; Srinivas R
Rapid Commun Mass Spectrom; 2018 Aug; 32(15):1181-1190. PubMed ID: 29723439
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of forced degradation products of sertraline hydrochloride using UPLC, ultra-high-performance liquid Chromatography-Quadrupole-Time of flight mass spectrometry (UHPLC-Q-TOF/MS/MS) and NMR.
Grover P; Bhardwaj M; Mukherjee D
J Pharm Biomed Anal; 2022 Nov; 221():115045. PubMed ID: 36126615
[TBL] [Abstract][Full Text] [Related]
5. LC/Q-TOF-MS-based structural characterization of enasidenib degradation products and establishment of a stability-indicating assay method: Insights into chemical stability.
Chakkar A; Chaturvedi S; Rajput N; Sengupta P; Sharma N
Rapid Commun Mass Spectrom; 2024 Mar; 38(5):e9696. PubMed ID: 38355880
[TBL] [Abstract][Full Text] [Related]
6. LC-MS/MS studies for identification and characterization of new forced degradation products of dabrafenib and establishment of their degradation pathway.
Grover P; Bhardwaj M; Mehta L
J Pharm Biomed Anal; 2021 Nov; 206():114351. PubMed ID: 34509659
[TBL] [Abstract][Full Text] [Related]
7. Structural characterization of alkaline and oxidative stressed degradation products of lurasidone using LC/ESI/QTOF/MS/MS.
Kumar Talluri MVN; Dharavath S; Kalariya PD; Prasanth B; Srinivas R
J Pharm Biomed Anal; 2015 Feb; 105():1-9. PubMed ID: 25527975
[TBL] [Abstract][Full Text] [Related]
8. Characterization of degradation products of macitentan under various stress conditions using liquid chromatography/mass spectrometry.
Yerra NV; Pallerla P; Pandeti S; Tabet JC; Thota JR
Rapid Commun Mass Spectrom; 2018 Jul; 32(13):1075-1084. PubMed ID: 29660192
[TBL] [Abstract][Full Text] [Related]
9. Study on forced degradation behaviour of dofetilide by LC-PDA and Q-TOF/MS/MS: Mechanistic explanations of hydrolytic, oxidative and photocatalytic rearrangement of degradation products.
Thalluri B; Dhiman V; Tiwari S; Baira SM; Kumar Talluri MVN
J Pharm Biomed Anal; 2020 Feb; 179():112985. PubMed ID: 31780282
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of stressed degradation products of prulifloxacin using LC-ESI-MS/Q-TOF, MSn experiments: development of a validated specific stability-indicating LC-MS method.
Raju B; Ramesh M; Srinivas R; Raju SS; Venkateswarlu Y
J Pharm Biomed Anal; 2011 Nov; 56(3):560-8. PubMed ID: 21783336
[TBL] [Abstract][Full Text] [Related]
11. Analytical method development, identification, and characterization of stress degradation products of idelalisib by ultrahigh-performance liquid chromatography with photodiode array and ultrahigh-performance liquid chromatography with electrospray ionization quadrupole time-of-flight mass spectrometry studies.
Mahesh M; Bali A; Gupta T
Rapid Commun Mass Spectrom; 2024 Jun; 38(11):e9745. PubMed ID: 38591150
[TBL] [Abstract][Full Text] [Related]
12. Validated stability indicating assay method of olaparib: LC-ESI-Q-TOF-MS/MS and NMR studies for characterization of its new hydrolytic and oxidative forced degradation products.
Thummar M; Kuswah BS; Samanthula G; Bulbake U; Gour J; Khan W
J Pharm Biomed Anal; 2018 Oct; 160():89-98. PubMed ID: 30075398
[TBL] [Abstract][Full Text] [Related]
13. Identification, characterisation and in silico ADMET prediction of ozenoxacin and its degradation products using high-performance liquid chromatography-photodiode array and liquid chromatography-quadrupole time-of-flight-tandem mass spectrometry.
Matta A; Sundararajan R
Rapid Commun Mass Spectrom; 2024 Feb; 38(3):e9676. PubMed ID: 38211348
[TBL] [Abstract][Full Text] [Related]
14. LC-ESI-MS/MS evaluation of forced degradation behaviour of silodosin: In vitro anti cancer activity evaluation of silodosin and major degradation products.
Vishnuvardhan C; Saibaba B; Allakonda L; Swain D; Gananadhamu S; Srinivas R; Satheeshkumar N
J Pharm Biomed Anal; 2017 Feb; 134():1-10. PubMed ID: 27866053
[TBL] [Abstract][Full Text] [Related]
15. Characterization of stress degradation products of duloxetine hydrochloride employing LC-UV/PDA and LC-MS/TOF studies.
Chadha R; Bali A; Bansal G
J Pharm Biomed Anal; 2016 Mar; 121():39-55. PubMed ID: 26775018
[TBL] [Abstract][Full Text] [Related]
16. Development of stability-indicating method for separation and characterization of benidipine forced degradation products using LC-MS/MS.
Kushwah BS; Thummar MM; Yadav AS; Dhiman V; Samanthula G
Biomed Chromatogr; 2023 Jan; 37(1):e5517. PubMed ID: 36200917
[TBL] [Abstract][Full Text] [Related]
17. Liquid chromatography electrospray ionization tandem mass spectrometry study of nilutamide and its stress degradation products: in silico toxicity prediction of degradation products.
Ramesh Babu A; Borkar RM; Raju G; Raju B; Srinivas R
Biomed Chromatogr; 2014 Jun; 28(6):788-93. PubMed ID: 24861745
[TBL] [Abstract][Full Text] [Related]
18. Isolation, characterization using LC-ESI-QTOF, NMR and in vitro cytotoxicity assay of niclosamide forced degradation products.
P J; Ch V; A L; V G M N; Ch N; N S
J Pharm Biomed Anal; 2017 Mar; 136():148-155. PubMed ID: 28081501
[TBL] [Abstract][Full Text] [Related]
19. Identification of hydrolytic and isomeric N-oxide degradants of vilazodone by on line LC-ESI-MS/MS and APCI-MS.
Kalariya PD; Talluri MV; Patel PN; Srinivas R
J Pharm Biomed Anal; 2015 Jan; 102():353-65. PubMed ID: 25459935
[TBL] [Abstract][Full Text] [Related]
20. Forced degradation studies of lansoprazole using LC-ESI HRMS and
Shankar G; Borkar RM; Suresh U; Guntuku L; Naidu VGM; Nagesh N; Srinivas R
J Mass Spectrom; 2017 Jul; 52(7):459-471. PubMed ID: 28544042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
